Warning: The NCBI web site requires JavaScript to function. more...
The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke.
Ahmad M, Saleem S, Shah Z, Maruyama T, Narumiya S, Doré S.
Exp Transl Stroke Med. 2010 Jul 8;2(1):12.
Related citations
Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia.
Saleem S, Shah ZA, Urade Y, Doré S.
Neuroscience. 2009 Apr 21;160(1):248-54. Epub 2009 Feb 28.
Neuroprotective properties of prostaglandin I2 IP receptor in focal cerebral ischemia.
Saleem S, Shah ZA, Maruyama T, Narumiya S, Doré S.
Neuroscience. 2010 Sep 29;170(1):317-23. Epub 2010 Jul 14.
Effects of prostanoid EP agonists on mouse intraocular pressure.
Saeki T, Ota T, Aihara M, Araie M.
Invest Ophthalmol Vis Sci. 2009 May;50(5):2201-8. Epub 2008 Dec 30.
Enhanced cortical reperfusion protects coagulation factor XII-deficient mice from ischemic stroke as revealed by high-field MRI.
Pham M, Kleinschnitz C, Helluy X, Bartsch AJ, Austinat M, Behr VC, Renné T, Nieswandt B, Stoll G, Bendszus M.
Neuroimage. 2010 Feb 15;49(4):2907-14. Epub 2009 Dec 1.
Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.
McCullough L, Wu L, Haughey N, Liang X, Hand T, Wang Q, Breyer RM, Andreasson K.
J Neurosci. 2004 Jan 7;24(1):257-68.
Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia.
Saleem S, Kim YT, Maruyama T, Narumiya S, Doré S.
J Neuroimmunol. 2009 Mar 31;208(1-2):87-93. Epub 2009 Feb 8.
Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
Kuriyama S, Kashiwagi H, Yuhki K, Kojima F, Yamada T, Fujino T, Hara A, Takayama K, Maruyama T, Yoshida A, Narumiya S, Ushikubi F.
Thromb Haemost. 2010 Oct;104(4):796-803. Epub 2010 Jul 20.
Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba (EGb 761) neuroprotection.
Shah ZA, Nada SE, Doré S.
Neuroscience. 2011 Apr 28;180:248-55. Epub 2011 Feb 18.
Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation.
Ahmad AS, Yun YT, Ahmad M, Maruyama T, Doré S.
Neurotox Res. 2008 Dec;14(4):343-51.
Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage.
Ahmad AS, Saleem S, Ahmad M, Doré S.
Toxicol Sci. 2006 Jan;89(1):265-70. Epub 2005 Oct 19.
PGF(2alpha) FP receptor contributes to brain damage following transient focal brain ischemia.
Saleem S, Ahmad AS, Maruyama T, Narumiya S, Doré S.
Neurotox Res. 2009 Jan;15(1):62-70. Epub 2009 Feb 11.
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Lack of protection with a novel, selective melanocortin receptor subtype-4 agonist RY767 in a rat transient middle cerebral artery occlusion stroke model.
Regan C, Shepherd C, Strack A, Weinberg D, Nargund R, Ye Z, Pollard P, Fong T, Reynolds I, Lynch J.
Pharmacology. 2009;83(1):38-44. Epub 2008 Dec 4.
Modulation of astrocytic activation by arundic acid (ONO-2506) mitigates detrimental effects of the apolipoprotein E4 isoform after permanent focal ischemia in apolipoprotein E knock-in mice.
Mori T, Town T, Tan J, Tateishi N, Asano T.
J Cereb Blood Flow Metab. 2005 Jun;25(6):748-62.
Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist.
Choudhary S, Alander C, Zhan P, Gao Q, Pilbeam C, Raisz L.
Prostaglandins Other Lipid Mediat. 2008 Jun;86(1-4):35-40. Epub 2008 Feb 29.
Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression.
Barone FC, White RF, Spera PA, Ellison J, Currie RW, Wang X, Feuerstein GZ.
Stroke. 1998 Sep;29(9):1937-50; discussion 1950-1.
Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat.
Candelario-Jalil E, Mhadu NH, González-Falcón A, García-Cabrera M, Muñoz E, León OS, Fiebich BL.
J Neuroinflammation. 2005 Jan 18;2(1):3.
Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.
Sung YM, He G, Fischer SM.
Cancer Res. 2005 Oct 15;65(20):9304-11.
Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke.
Barone FC, Hillegass LM, Tzimas MN, Schmidt DB, Foley JJ, White RF, Price WJ, Feuerstein GZ, Clark RK, Griswold DE, et al.
Mol Chem Neuropathol. 1995 Jan;24(1):13-30.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on